Researchers have found that LLM-driven bug finding is not a drop-in replacement for mature static analysis pipelines. Studies comparing AI coding agents to human developers show that while AI can be ...

Every developer should be paying attention to the local-first architecture movement and what it means for JavaScript. Here’s ...

Major League Baseball Pitch, Hit & Run is a free event that provides boys and girls -- ages 7 to 14 -- an opportunity to showcase their baseball and softball skills, while earning a chance to attend ...

The 2026 NCAA Tournament is one week away, with Selection Sunday arriving on March 15. Once brackets are revealed, there are only a few days before the tournament officially begins, so now is the ...

Most developers don’t wake up and say “I choose OpenJDK 11 because it’s my comfort runtime.” Let’s be real. If you’re still on 11 in 2025, it’s usually not because you want to be. It’s because ...

Investors wiped $40 billion from IBM's market cap after Anthropic released COBOL translation tools. Analysts say the market ...

Inside an unassuming building in Winnipeg's core, a small team is working to protect people from dangerous street drugs. Main Street Project's safe supply program provides those addicted primarily to ...

Students said the idea for the project started about two years ago. BBC hits back in Trump's $10 billion lawsuit US judge throws out immigration board's ruling endorsing Trump mass detention policy ...

BP has suspended its share buyback program and increased its cost-cutting goal by $1.5 billion to bolster its balance sheet and increase investment in oil production. The company's current struggles ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.